Intravenous Nalbuphine for Prevention of Intrathecal Morphine-induced Nausea and Vomiting in Patients Undergoing Cesarean Section: A Double-blind, Randomized Controlled Trial.

• Status: COMPLETED
• Trial end date: 2025-08-30

Summary

We study efficacy of iv nalbuphine in prevention of intrathecal morphine-induced nausea and vomiting in patients undergoing cesarean section.

• Phase: NA

Details

• Lead Sponsor: Thammasat University
• Treatments: Nalbuphine